Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.

Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-naive Parkinson's disease patients

Open access

Abstract

BACKGROUND: Parkinson's disease (PD) presently is conceptualized as a protein aggregation disease in which pathology involves both the enteric and the central nervous system, possibly spreading from one to another via the vagus nerves. As gastrointestinal dysfunction often precedes or parallels motor symptoms, the enteric system with its vast diversity of microorganisms may be involved in PD pathogenesis. Alterations in the enteric microbial taxonomic level of L-DOPA-naïve PD patients might also serve as a biomarker. METHODS: We performed metagenomic shotgun analyses and compared the fecal microbiomes of 31 early stage, L-DOPA-naïve PD patients to 28 age-matched controls. RESULTS: We found increased Verrucomicrobiaceae (Akkermansia muciniphila) and unclassified Firmicutes, whereas Prevotellaceae (Prevotella copri) and Erysipelotrichaceae (Eubacterium biforme) were markedly lowered in PD samples. The observed differences could reliably separate PD from control with a ROC-AUC of 0.84. Functional analyses of the metagenomes revealed differences in microbiota metabolism in PD involving the ẞ-glucuronate and tryptophan metabolism. While the abundances of prophages and plasmids did not differ between PD and controls, total virus abundance was decreased in PD participants. Based on our analyses, the intake of either a MAO inhibitor, amantadine, or a dopamine agonist (which in summary relates to 90% of PD patients) had no overall influence on taxa abundance or microbial functions. CONCLUSIONS: Our data revealed differences of colonic microbiota and of microbiota metabolism between PD patients and controls at an unprecedented detail not achievable through 16S sequencing. The findings point to a yet unappreciated aspect of PD, possibly involving the intestinal barrier function and immune function in PD patients. The influence of the parkinsonian medication should be further investigated in the future in larger cohorts.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s13073-017-0428-y

Cites

88 of 88 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Genus and species level differences in PD participants and controls. a NMDS ordination of all samples used in this study, using a Bray–Curtis between-sample distance at genus level. This shows the composition relatedness of samples and that PD samples form a subgroup. Outliers denoted with # took antibiotics in a period of 28–34 days prior to feces sampling. See also Additional file 2 for taxonomic analysis while taking these samples into account. b Genus-level sample composition. c The most significant species or groups of taxa that could not be further classified. Unclassified Prevotella is not significant after multiple testing, but was implied in PD in several studies (see “Discussion”). d Species correlating strongest to PD disease severity (as measured by UPDRS III). Note that after multiple testing correction, these are all q > 0.1
Fig. 1 Genus and species level differences in PD participants and controls. a NMDS ordination of all samples used in this study, using a Bray–Curtis between-sample distance at genus level. This shows the composition relatedness of samples and that PD samples form a subgroup. Outliers denoted with # took antibiotics in a period of 28–34 days prior to feces sampling. See also Additional file 2 for taxonomic analysis while taking these samples into account. b Genus-level sample composition. c The most significant species or groups of taxa that could not be further classified. Unclassified Prevotella is not significant after multiple testing, but was implied in PD in several studies (see “Discussion”). d Species correlating strongest to PD disease severity (as measured by UPDRS III). Note that after multiple testing correction, these are all q > 0.1CC BY · PubMed Central
Fig. 2 Functional differences in PD patients based on selected metabolic pathways. a Phylum and (b) genus level composition of six modules that were increased/decreased in PD patients. c All genera were contributing to these modules as expected by random chance, with the exception of MF0065 and MF0118, where a higher than expected proportion of reads contributing could be traced to Eubacterium in PD patients
Fig. 2 Functional differences in PD patients based on selected metabolic pathways. a Phylum and (b) genus level composition of six modules that were increased/decreased in PD patients. c All genera were contributing to these modules as expected by random chance, with the exception of MF0065 and MF0118, where a higher than expected proportion of reads contributing could be traced to Eubacterium in PD patientsCC BY · PubMed Central
Fig. 3 Classification of PD participants based on their microbiome. Here the classifier selected a very similar set of features as were determined by univariate testing (Fig. 1). With only six genera, PD could be separated from control patients with an AUC of 0.84. The exact mOTU composition of each feature is given in Additional file 15
Fig. 3 Classification of PD participants based on their microbiome. Here the classifier selected a very similar set of features as were determined by univariate testing (Fig. 1). With only six genera, PD could be separated from control patients with an AUC of 0.84. The exact mOTU composition of each feature is given in Additional file 15CC BY · PubMed Central
Fig. 4 Structural equation modeling (SEM). SEM analysis of PD in relation to key correlating bacterial functions and taxa (MSEA = 0, PCLOSE = 0.79, AIC = 59.385). Values on paths and boxes are standardized regression and determination coefficients (R2), respectively. Dashed lines and red colors denote negative relationships. The thickness of lines is proportional to regression coefficients. All relationships are statistically significant (P < 0.05, Additional file 5). AIC Akaike information criterion, MSEA mean square error of approximation, PCLOSE probability of close fit
Fig. 4 Structural equation modeling (SEM). SEM analysis of PD in relation to key correlating bacterial functions and taxa (MSEA = 0, PCLOSE = 0.79, AIC = 59.385). Values on paths and boxes are standardized regression and determination coefficients (R2), respectively. Dashed lines and red colors denote negative relationships. The thickness of lines is proportional to regression coefficients. All relationships are statistically significant (P < 0.05, Additional file 5). AIC Akaike information criterion, MSEA mean square error of approximation, PCLOSE probability of close fitCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 88 references

Cited by

See all 642

Metadata

Authors
Bedarf, J. R., Hildebrand, F., Coelho, L. P., Sunagawa, S., Bahram, M., Goeser, F., Bork, P., & Wüllner, U.
Affiliations
  • University of Bonn (DE)
  • European Molecular Biology Laboratory (DE)
  • ETH Zurich (CH)
  • Uppsala University (SE)
Corresponding author
Wüllner, U.
Venue
Genome Medicine
Published
2017-04-28
Volume
9
Issue
1
Pages
39-39
ISSN
1756-994X (ISSN-L)
OpenAlex
W2608965099
Cited by
642
References
88
Citations by year
2026: 54 · 2025: 71 · 2024: 69 · 2023: 74 · 2022: 90 · 2021: 97 · 2020: 70 · 2019: 61 · 2018: 46 · 2017: 10
FWCI
20.78
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Genome Medicine (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (acceptedVersion)
  • Uppsala University Publications (Uppsala University) (submittedVersion, other-oa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • DZNE Pub (submittedVersion, cc-by)
  • Repository for Publications and Research Data (ETH Zurich) (submittedVersion, cc-by)
  • ETH Zürich Research Collection (cc-by)
Funders
  • PD Fonds Germany gGmbH
  • European Union’s Horizon 2020 research and innovation program, (no. 600375)
  • partly funded by grants of the German Center for Infection Research (DZIF)
  • Helmut Horten Foundation
  • Helge Ax:son Johnsons Stiftelse and PUT1317
  • European Research Council (ERC) Microbios (ERC-AdG-669830)
  • EU/EFPIA Innovative Medicines Initiative Joint Undertaking Aetionomy (grant number 115568)
  • partly supported by the European Molecular Biology Laboratory (EMBL)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
Keywords
Parkinson's disease, gut microbiota, gut metagenome, Akkermansia muciniphila, Verrucomicrobiaceae, Prevotella copri, tryptophan metabolism, virome, prophages, plasmids, gut-brain axis, vagus nerve, biomarkers, monoamine oxidase inhibitors, amantadine, dopamine agonists, intestinal barrier function
MeSH terms
Gastrointestinal Microbiome, Aged, Bacteria, Humans, Levodopa, Male, Middle Aged, Parkinson Disease, Viruses, Sequence Analysis, DNA, Metagenome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-naive Parkinson's disease patients. https://app.cochat.ai/papers/10.1186/s13073-017-0428-y
The paper
Bedarf, J. R., Hildebrand, F., Coelho, L. P., Sunagawa, S., Bahram, M., Goeser, F., Bork, P., & Wüllner, U. (2017). Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-naive Parkinson's disease patients. Genome Medicine. https://doi.org/10.1186/s13073-017-0428-y

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.